Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing;Új antioxidáns terápiás stratégiák az idoskori cardiovascularis diszfunkció kezelésében

Orvosi Hetilap

Volumn 149, Issue 50, 2008, Pages 2377-2385

  Radovits, Tamás ^a,b  

^a Ruprecht Karls Universität Heidelberg   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Ageing; Cardiovascular system; Nitro oxidative stress; PARP; Peroxynitrite

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; CARDIOVASCULAR AGENT; FP 15; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITROPRUSSIDE SODIUM; PEROXYNITRITE; UNCLASSIFIED DRUG; FREE RADICAL; PEROXYNITROUS ACID;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CATALYSIS; CATALYST; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; HEART CATHETERIZATION; HEART FUNCTION TEST; HEART LEFT VENTRICLE PRESSURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; AORTA; BIOSYNTHESIS; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; DRUG ANTAGONISM; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; METABOLISM; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

AGING; ANIMALS; ANTIOXIDANTS; AORTA; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; ENDOTHELIUM, VASCULAR; FREE RADICALS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; OXIDATIVE STRESS; PEROXYNITROUS ACID; POLY(ADP-RIBOSE) POLYMERASES; RATS; SIGNAL TRANSDUCTION; UP-REGULATION; VASODILATION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 58349101128     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28502     Document Type: Article

References (10)

1. Lakatta, E. G., Levy, D.: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: a "set up" for vascular disease. Circulation, 2003, 107, 139-146.
2. Lelbach Á., Székács B.: Az öregedés biológiai és élettani vonatkozásai. In: Geriátria. Az idöskor gyógyászata. Szerk.: Székács B. Semmelweis Kiadó, Budapest, 2005, 7-13.
3. Pacher, P., Beckman, J. S., Liaudet, L.: Nitric oxide and peroxynitrite in health and disease. Physiol. Rev., 2007, 87, 315-424.
4. Pacher, P., Szabo, C.: Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors. Cardiovasc. Drug Rev., 2007, 25, 235-260.
5. Andrabi, S. A., Kim, N. S., Yu, S. W. és mtsai: Poly(ADP-ribose) (PAK) polymer is a death signal. Proc. Natl. Acad. Sci. USA, 2006, 103, 18308-18313.
6. Csiszar, A., Pacher, P., Kaley, G. és mtsa: Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr. Vasc. Pharmacol., 2005, 3, 285-291.
7. Radovits, T., Lin, L. N., Zotkina, J. és mtsai: Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro. Eur. J. Pharmacol., 2007, 564, 158-166.
8. Radovits, T., Seres, L., Gerö, D. és mtsai: Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp. Gerontol., 2007, 42, 676-685.
9. Radovits, T., Seres, L., Gerö, D. és mtsai: The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech. Ageing Dev., 2007, 128, 173-181.
10. Radovits T., Gerö D., Kékesi V. és mtsai: FP15, a peroxinitrit lebontásának katalizátora javítja az öregkori cardiovascularis diszfunkciót. Cardiol. Hung., 2007, 37, 267-275.